The complex shape of respiratory syncytial virus (RSV) is one hurdle limiting the development of treatments for an infection ...

Olympic gold medalist gymnast Shawn Johnson East had respiratory syncytial virus-related experiences with all 3 of her ...

Every year, millions of infants are infected by a little-known virus that is the most common cause of respiratory disease in children. Respiratory syncytial virus (RSV) (Fig. 1) causes a spectrum ...

Pfizer's RSV vaccine Abrysvo receives FDA approval for adults 18-59 at high risk, with extended use for pregnant individuals ...

The patient's sample is added to the port, where antibodies targeting the virus fusion protein can bind the antigen in the sample. Capillary action migrates the resultant complex along the strip ...

Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the ...

GSK presents positive data for AREXVY, its respiratory syncytial virus (RSV) vaccine, indicating protection over three RSV ...

New images of the virus may hold the key to preventing or slowing RSV infections. RSV is of greatest concern in young children, the elderly and adults. The complex shape of respiratory syncytial ...

Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

New images of the virus from researchers at ... Sibert et al, Assembly of respiratory syncytial virus matrix protein lattice and its coordination with fusion glycoprotein trimers, Nature ...

RSV F proteins, shown in this image created by University of Wisconsin ... MADISON — The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments ...

New images of the virus from researchers at the University ... Reference: Sibert BS, Kim JY, Yang JE, et al. Assembly of respiratory syncytial virus matrix protein lattice and its coordination with ...